FDA Inspection 750019 — Chartwell Pharmaceuticals Amityville, LLC

Chartwell Pharmaceuticals Amityville, LLC — FEI 2433247

The FDA completed an inspection of Chartwell Pharmaceuticals Amityville, LLC on October 19, 2011 in Amityville, NY. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 7 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 19, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Amityville, NY (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
117721 CFR 211.63Equipment Design, Size and Location
191221 CFR 211.166(a)Written program not followed
241921 CFR 211.198(a)Complaint Handling Procedure
358521 CFR 211.110(a)Control procedures to monitor and validate performance
363921 CFR 211.204Returned drug procedures in writing and followed
434021 CFR 211.142Written warehousing procedures established/followed